FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313880188> ?p ?o ?g. }

• W4313880188 endingPage "8330" @default.
• W4313880188 startingPage "8319" @default.
• W4313880188 abstract "Abstract Background Identifying therapeutic targets and prognostic biomarkers significantly contributes to individualized treatment of acute myeloid leukemia (AML). Dihydropyrimidinase‐like 2 (DPYSL2) expression was decreased in homoharringtonine (HHT)‐resistant AML cells, which were established by our group. DPYSL2 plays an important role in axon growth and has oncogene effect in glioblastoma. However, little research has been conducted to investigate the function of DPYSL2 in AML pathogenesis. Methods Auto‐docking was used to reveal the targeting relationship between HHT and DPYSL2. Overall survival (OS), event‐free survival (EFS), and relapse‐free survival (RFS) were used to evaluate the prognostic impact of DPYSL2 for AML. ShRNA was used to knockdown the expression of SPATS2L. Apoptosis was assessed by flow cytometry. In vivo growth and survival were assessed using a xenotransplantation mice model. RNA sequencing was performed to elucidate the molecular mechanisms underlying the role of SPATS2L in AML and were confirmed by Western blot. Results We found DPYSL2 was the target of HHT. Next, we found AML cell lines and patients had higher DPYSL2 expression levels than the normal samples. Further multivariate analysis demonstrated that high DPYSL2 expression was an independent poor prognostic factor for OS, EFS, and RFS in AML. Inhibition of DPYSL2 expression suppressed cell growth, induced apoptosis in AML cell lines, and prolonged the survival of AML xenograft NCG mice. Through RNA‐seq analysis from TCGA and our data, the JAK2/STAT3/STAT5‐PI3K P85/AKT/GSK3b axis was thought to be the critical pathway in regulating DPYSL2 in AML development. Conclusions We first time confirmed that DPYSL2 was a target of HHT and played an oncogene role in AML by regulating JAK/STAT signaling pathway. Therefore, DPYSL2 could serve as a novel prognostic marker and therapeutic target for AML treatment." @default.
• W4313880188 created "2023-01-10" @default.
• W4313880188 creator A5002928156 @default.
• W4313880188 creator A5004760143 @default.
• W4313880188 creator A5011862811 @default.
• W4313880188 creator A5011932783 @default.
• W4313880188 creator A5028634125 @default.
• W4313880188 creator A5031804038 @default.
• W4313880188 creator A5039972688 @default.
• W4313880188 creator A5040558103 @default.
• W4313880188 creator A5041618632 @default.
• W4313880188 creator A5044809089 @default.
• W4313880188 creator A5048616051 @default.
• W4313880188 creator A5059913267 @default.
• W4313880188 creator A5072500806 @default.
• W4313880188 creator A5076078835 @default.
• W4313880188 creator A5079738340 @default.
• W4313880188 creator A5080088656 @default.
• W4313880188 creator A5086581375 @default.
• W4313880188 creator A5088054409 @default.
• W4313880188 creator A5088804819 @default.
• W4313880188 date "2023-01-09" @default.
• W4313880188 modified "2023-10-16" @default.
• W4313880188 title "Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia" @default.
• W4313880188 cites W1520634183 @default.
• W4313880188 cites W1564192489 @default.
• W4313880188 cites W1968770896 @default.
• W4313880188 cites W1971240883 @default.
• W4313880188 cites W1979548320 @default.
• W4313880188 cites W1982465307 @default.
• W4313880188 cites W1984132555 @default.
• W4313880188 cites W2034847306 @default.
• W4313880188 cites W2054245055 @default.
• W4313880188 cites W2063120457 @default.
• W4313880188 cites W2098272196 @default.
• W4313880188 cites W2105668062 @default.
• W4313880188 cites W2112079439 @default.
• W4313880188 cites W2124759033 @default.
• W4313880188 cites W2127912482 @default.
• W4313880188 cites W2129864392 @default.
• W4313880188 cites W2152319267 @default.
• W4313880188 cites W2154227027 @default.
• W4313880188 cites W2159363584 @default.
• W4313880188 cites W2472104278 @default.
• W4313880188 cites W2476740080 @default.
• W4313880188 cites W2547984099 @default.
• W4313880188 cites W2563351325 @default.
• W4313880188 cites W2572765151 @default.
• W4313880188 cites W2715749014 @default.
• W4313880188 cites W2725930552 @default.
• W4313880188 cites W2736730167 @default.
• W4313880188 cites W2774533007 @default.
• W4313880188 cites W2903407606 @default.
• W4313880188 cites W2911121386 @default.
• W4313880188 cites W2943489262 @default.
• W4313880188 cites W2962354828 @default.
• W4313880188 cites W2965906059 @default.
• W4313880188 cites W2980911308 @default.
• W4313880188 cites W2986834274 @default.
• W4313880188 cites W2995231009 @default.
• W4313880188 cites W3020803734 @default.
• W4313880188 cites W3023575816 @default.
• W4313880188 cites W3033124631 @default.
• W4313880188 cites W3105505291 @default.
• W4313880188 cites W4287025205 @default.
• W4313880188 cites W4313880188 @default.
• W4313880188 doi "https://doi.org/10.1002/cam4.5531" @default.
• W4313880188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36621846" @default.
• W4313880188 hasPublicationYear "2023" @default.
• W4313880188 type Work @default.
• W4313880188 citedByCount "2" @default.
• W4313880188 countsByYear W43138801882023 @default.
• W4313880188 crossrefType "journal-article" @default.
• W4313880188 hasAuthorship W4313880188A5002928156 @default.
• W4313880188 hasAuthorship W4313880188A5004760143 @default.
• W4313880188 hasAuthorship W4313880188A5011862811 @default.
• W4313880188 hasAuthorship W4313880188A5011932783 @default.
• W4313880188 hasAuthorship W4313880188A5028634125 @default.
• W4313880188 hasAuthorship W4313880188A5031804038 @default.
• W4313880188 hasAuthorship W4313880188A5039972688 @default.
• W4313880188 hasAuthorship W4313880188A5040558103 @default.
• W4313880188 hasAuthorship W4313880188A5041618632 @default.
• W4313880188 hasAuthorship W4313880188A5044809089 @default.
• W4313880188 hasAuthorship W4313880188A5048616051 @default.
• W4313880188 hasAuthorship W4313880188A5059913267 @default.
• W4313880188 hasAuthorship W4313880188A5072500806 @default.
• W4313880188 hasAuthorship W4313880188A5076078835 @default.
• W4313880188 hasAuthorship W4313880188A5079738340 @default.
• W4313880188 hasAuthorship W4313880188A5080088656 @default.
• W4313880188 hasAuthorship W4313880188A5086581375 @default.
• W4313880188 hasAuthorship W4313880188A5088054409 @default.
• W4313880188 hasAuthorship W4313880188A5088804819 @default.
• W4313880188 hasBestOaLocation W43138801881 @default.
• W4313880188 hasConcept C121608353 @default.
• W4313880188 hasConcept C126322002 @default.
• W4313880188 hasConcept C143998085 @default.
• W4313880188 hasConcept C173396325 @default.
• W4313880188 hasConcept C181199279 @default.

• next